LA JOLLA, CA, UNITED STATES, March 9, 2021 /EINPresswire.com/ -- CureMetrix, Inc., a global healthcare technology company that develops AI-driven software announced that medical industry veteran Tracy John Robertson has joined the company as executive vice president of business development.
“Building on the success, award-winning recognition and robust pipeline of innovations in the CureMetrix portfolio, we are excited to welcome Mr. Robertson to our executive team,” said Navid Alipour, chief executive officer of CureMetrix. “Our mission is to improve cancer survival rates worldwide; and Tracy Robertson brings the commercial experience, business acumen and a collaborative approach that will be key to furthering our globally-focused business development strategy. He has a proven record of driving shareholder value through programs that deliver sustained and profitable growth, increased brand awareness and enhanced customer satisfaction,” said Mr. Alipour.
In his role with CureMetrix, Robertson’s focus will be on continuing the CureMetrix expansion into new markets by augmenting its solution portfolio to drive client outcomes, identifying new business ventures and value-creation through the development of a global network of clinical and strategic partnerships.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Robertson, an accomplished business development leader brings more than three decades of healthcare experience spanning the Americas, UK, EU, and the Asia-Pacific region. His expertise includes clinical imaging and research, commercial sales, product marketing, general management, collaboration management and the development of diagnostic imaging centers and oncology treatment facilities. With a background in Radiologic Technology and MRI Clinical-Research, he led a division of GE Healthcare’s Advanced MRI Applications Group before establishing a global MRI Consultancy.
Robertson also spent 16 years with Siemens Healthcare in progressive global management roles before leading the commercialization efforts of two emerging-market technology firms, serving as chief operating officer and chief marketing officer. Prior to joining CureMetrix, Mr. Robertson spent the past five years with VasoHealthcare – an authorized representative of GE Healthcare – where he led the Women’s Health Group since 2017.
Regarding the opportunity to join CureMetrix, Robertson says, “I am excited and humbled to join this matrix of extraordinary commercial and scientific talent, supported by a world-class team of clinical and strategic advisors. I look forward to my role in helping CureMetrix bring life-saving, AI-based solutions to the market – especially the community of healthcare providers, radiologists, referring physicians, and the patients they serve.”